Condition
Correction of Functional Deformity
Total Trials
7
Recruiting
0
Active
4
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Active Not Recruiting4
Completed2
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT03423953Active Not Recruiting
Comprehensive Nano - Post Market Clinical Follow-Up Study
NCT05500066Enrolling By Invitation
Tornier HRS (Humeral Reconstruction System) Study (REVIVE)
NCT03409718Active Not Recruiting
Database Retrieval for the Comprehensive Shoulder
NCT03266874Active Not Recruiting
G7 BiSpherical Acetabular Shell PMCF Study
NCT04255394Completed
Exceed ABT Acetabular Cup Cementless System
NCT04301622Active Not Recruiting
Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur
NCT03409666Not ApplicableCompleted
Randomized Controlled RSA Study Comparing the Taperloc Complete Versus the Taperloc Complete Microplasty.
Showing all 7 trials